세계의 테스토스테론 대체 요법 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 적응증별, 제품 유형별, 유효 성분별, 유통 경로별, 지역별, 경쟁별(2020-2030년)
Testosterone Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Product Type, By Drug Active, By Distribution Channel, By Region and Competition, 2020-2030F
상품코드:1728089
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 181 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 테스토스테론 대체 요법 시장은 2024년에 5억 8,726만 달러로 평가되었고, 2030년에는 9억 4,753만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR은 8.30%를 나타낼 것으로 예측됩니다.
테스토스테론 대체 요법(TRT)은 테스토스테론 결핍 또는 성선 기능 저하증으로 진단받은 환자를 치료하기 위해 설계된 의료적 개입입니다. 이 질환은 노년층 남성에서 더 흔히 발생하며, 피로, 근육량 감소, 성욕 감소, 기분 변화 등 증상을 유발할 수 있습니다. TRT는 일반적으로 철저한 의료 평가와 호르몬 수치 평가를 거쳐 맞춤형 치료 계획으로 진행됩니다. 테스토스테론 결핍과 남성 건강에 미치는 영향에 대한 인식 향상, 그리고 국소 젤, 장기 작용 주사제, 구강용 정제 등 더 편리한 투여 방법의 개발이 시장 성장을 촉진했습니다. 또한 고령화 인구 증가와 맞춤형 의료 서비스의 확산은 TRT 수요 증가에 결정적인 역할을 했습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
5억 8,726만 달러
시장 규모(2030년)
9억 4,753만 달러
CAGR(2025-2030년)
8.30%
급성장 부문
온라인 약국
최대 시장
북미
시장 성장 촉진요인
약물전달의 발전
시장의 과제
편견과 오해
주요 시장 동향
맞춤형 치료 계획
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 테스토스테론 대체 요법 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
적응증별(자가면역 질환, 유전성 질환, 성선 기능 저하증, 생식기 수술)
제품 유형별(구강용 정제, 젤 또는 크림, 임플란트, 경구, 비경구, 패치)
유효 성분별(메틸테스토스테론, 테스토스테론시피오네이트, 테스토스테론에난토산에스테르)
유통 경로별(병원 약국, 온라인 약국, 소매 약국)
국가별
기업별(2024년)
시장 맵
제6장 아시아태평양의 테스토스테론 대체 요법 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
호주
일본
한국
제7장 유럽 테스토스테론 대체 요법 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
스페인
이탈리아
영국
제8장 북미의 테스토스테론 대체 요법 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제9장 남미의 테스토스테론 대체 요법 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카 남성호르몬 보충치료 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 세계의 테스토스테론 대체 요법 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 PESTEL 분석
제16장 경쟁 구도
AbbVie Inc.
Bausch Health Companies Inc.
Teva Pharmaceutical Industries Ltd.
Perrigo Company plc
Cipla Limited
Sun Pharmaceuticals Industries Ltd.
Johnsons 및 Johnsons Services Inc
Sanofi SA
GSK Plc.
Pfizer Inc.
제17장 전략적 제안
제18장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global Testosterone Replacement Therapy Market was valued at USD 587.26 Million in 2024 and is anticipated to reach USD 947.53 Million by 2030, expanding at a CAGR of 8.30% during the forecast period. Testosterone Replacement Therapy (TRT) is a medical intervention designed to treat individuals diagnosed with testosterone deficiency or hypogonadism. This condition, more prevalent in aging men, can lead to symptoms such as fatigue, reduced muscle mass, decreased libido, and mood fluctuations. TRT typically begins with thorough medical assessments and hormone level evaluations, followed by tailored treatment plans. Increased awareness of testosterone deficiency and its impact on men's health, along with the development of more convenient delivery methods-including topical gels, long-acting injectables, and buccal tablets-has fueled market growth. Additionally, the aging population and rise of personalized healthcare have played a critical role in the growing demand for TRT.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 587.26 Million
Market Size 2030
USD 947.53 Million
CAGR 2025-2030
8.30%
Fastest Growing Segment
Online Pharmacy
Largest Market
North America
Key Market Drivers
Advancements in Drug Delivery
Recent innovations in drug delivery systems have significantly improved the efficacy and convenience of Testosterone Replacement Therapy. Transdermal patches are favored for their consistent hormone release and discreet application on the skin. Topical gels, like AndroGel and Testim, are easily applied and allow flexible dosing. Buccal tablets, placed between the gum and cheek, offer a non-invasive alternative for those avoiding injections. Long-acting injectables, such as testosterone undecanoate, require less frequent administration-every 8 to 12 weeks-enhancing patient compliance. Testosterone pellets, implanted subcutaneously, provide long-term hormone delivery with minimal maintenance. Nasal gel formulations and emerging micro-needle patches offer additional non-invasive methods for testosterone administration. Furthermore, implantable devices under development aim to deliver continuous hormone release over extended periods. With telemedicine integration, patients now have easier access to consultations and prescriptions, improving adherence and broadening the market's reach.
Key Market Challenges
Stigma and Misconceptions
The market faces challenges stemming from societal stigma and misunderstandings surrounding TRT. A common misconception is that TRT is predominantly used for athletic performance enhancement, overshadowing its legitimate use in medically diagnosed hypogonadism. Negative associations with steroid abuse in sports further fuel skepticism and distrust. Additionally, overpromotion of "Low T" symptoms in media campaigns has raised concerns about overdiagnosis and inappropriate prescriptions. Fears surrounding side effects and perceived risks can discourage both patients and physicians from considering TRT. Cultural attitudes linking testosterone deficiency to diminished masculinity may prevent men from seeking help, reinforcing feelings of embarrassment. Moreover, insufficient knowledge among both healthcare providers and the public can lead to hesitancy or misinformation about the therapy's effectiveness and safety.
Key Market Trends
Customized Treatment Plans
Customized treatment plans are becoming central to Testosterone Replacement Therapy, emphasizing individualized, patient-centric approaches. These plans involve comprehensive evaluations to determine the optimal dosage and method of administration based on each patient's hormone levels, symptoms, and medical history. Ongoing monitoring ensures that treatment remains both effective and safe, allowing timely adjustments to dosage or delivery method. Healthcare providers also assess other health factors, such as cardiovascular and prostate health, to mitigate risks. Lifestyle aspects-such as diet, sleep, exercise, and stress-are increasingly integrated into treatment strategies to maximize results. Patients are actively engaged in their care decisions, selecting preferred delivery options like gels, injections, patches, or buccal tablets, which enhances satisfaction and treatment adherence. The growing emphasis on personalization reflects broader trends in modern medicine and supports better health outcomes.
Key Market Players
AbbVie Inc.
Bausch Health Companies Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Perrigo Company plc
Cipla Limited
Sun Pharmaceuticals Industries Ltd.
Sanofi SA
Johnsons & Johnsons Services Inc
GSK Plc.
Report Scope:
In this report, the Global Testosterone Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Testosterone Replacement Therapy Market, By Indication:
Autoimmune Conditions
Genetic Disorders
Hypogonadism
Sex Organ Surgeries
Testosterone Replacement Therapy Market, By Product Type:
Buccal Adhesive
Gel or Creams
Implants
Oral
Parenteral
Patches
Testosterone Replacement Therapy Market, By Drug Active:
Methyltestosterone
Testosterone Cypionate
Testosterone Enanthate
Testosterone Replacement Therapy Market, By Distribution Channel:
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Testosterone Replacement Therapy Market, By Region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Testosterone Replacement Therapy Market.
Available Customizations:
Global Testosterone Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Testosterone Replacement Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism, Sex Organ Surgeries)
5.2.2. By Product Type (Buccal Adhesive, Gel or Creams, Implants, Oral, Parenteral, Patches)
5.2.3. By Drug Active (Methyltestosterone, Testosterone Cypionate, Testosterone Enanthate)
5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
5.2.5. By Country
5.2.6. By Company (2024)
5.3. Market Map
6. Asia Pacific Testosterone Replacement Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Indication
6.2.2. By Product Type
6.2.3. By Drug Active
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Testosterone Replacement Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Indication
6.3.1.2.2. By Product Type
6.3.1.2.3. By Drug Active
6.3.1.2.4. By Distribution Channel
6.3.2. India Testosterone Replacement Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Indication
6.3.2.2.2. By Product Type
6.3.2.2.3. By Drug Active
6.3.2.2.4. By Distribution Channel
6.3.3. Australia Testosterone Replacement Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Indication
6.3.3.2.2. By Product Type
6.3.3.2.3. By Drug Active
6.3.3.2.4. By Distribution Channel
6.3.4. Japan Testosterone Replacement Therapy Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Indication
6.3.4.2.2. By Product Type
6.3.4.2.3. By Drug Active
6.3.4.2.4. By Distribution Channel
6.3.5. South Korea Testosterone Replacement Therapy Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Indication
6.3.5.2.2. By Product Type
6.3.5.2.3. By Drug Active
6.3.5.2.4. By Distribution Channel
7. Europe Testosterone Replacement Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Product Type
7.2.3. By Drug Active
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Testosterone Replacement Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Indication
7.3.1.2.2. By Product Type
7.3.1.2.3. By Drug Active
7.3.1.2.4. By Distribution Channel
7.3.2. Germany Testosterone Replacement Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Indication
7.3.2.2.2. By Product Type
7.3.2.2.3. By Drug Active
7.3.2.2.4. By Distribution Channel
7.3.3. Spain Testosterone Replacement Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Indication
7.3.3.2.2. By Product Type
7.3.3.2.3. By Drug Active
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Testosterone Replacement Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Indication
7.3.4.2.2. By Product Type
7.3.4.2.3. By Drug Active
7.3.4.2.4. By Distribution Channel
7.3.5. United Kingdom Testosterone Replacement Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Indication
7.3.5.2.2. By Product Type
7.3.5.2.3. By Drug Active
7.3.5.2.4. By Distribution Channel
8. North America Testosterone Replacement Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Product Type
8.2.3. By Drug Active
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Testosterone Replacement Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Indication
8.3.1.2.2. By Product Type
8.3.1.2.3. By Drug Active
8.3.1.2.4. By Distribution Channel
8.3.2. Mexico Testosterone Replacement Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Indication
8.3.2.2.2. By Product Type
8.3.2.2.3. By Drug Active
8.3.2.2.4. By Distribution Channel
8.3.3. Canada Testosterone Replacement Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Indication
8.3.3.2.2. By Product Type
8.3.3.2.3. By Drug Active
8.3.3.2.4. By Distribution Channel
9. South America Testosterone Replacement Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Product Type
9.2.3. By Drug Active
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Testosterone Replacement Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Indication
9.3.1.2.2. By Product Type
9.3.1.2.3. By Drug Active
9.3.1.2.4. By Distribution Channel
9.3.2. Argentina Testosterone Replacement Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Indication
9.3.2.2.2. By Product Type
9.3.2.2.3. By Drug Active
9.3.2.2.4. By Distribution Channel
9.3.3. Colombia Testosterone Replacement Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Indication
9.3.3.2.2. By Product Type
9.3.3.2.3. By Drug Active
9.3.3.2.4. By Distribution Channel
10. Middle East and Africa Testosterone Replacement Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Product Type
10.2.3. By Drug Active
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Testosterone Replacement Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Indication
10.3.1.2.2. By Product Type
10.3.1.2.3. By Drug Active
10.3.1.2.4. By Distribution Channel
10.3.2. Saudi Arabia Testosterone Replacement Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Indication
10.3.2.2.2. By Product Type
10.3.2.2.3. By Drug Active
10.3.2.2.4. By Distribution Channel
10.3.3. UAE Testosterone Replacement Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Indication
10.3.3.2.2. By Product Type
10.3.3.2.3. By Drug Active
10.3.3.2.4. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Testosterone Replacement Therapy Market: SWOT Analysis
